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The data was analyzed using statistical mean, chi-square 
and P value. Deductions observed were then discussed.
Results
Of the 202 Salivary Gland tumours received, a total of 128 
were benign salivary gland tumours (fig. 1). Out of this 69 
(54%) were males and 59 (46%) were females (fig 2) with a 
male to female ratio of 1:2:1.
The age range for the benign tumours was between 4-
49years with the age group 31-40 years accounting for the 
highest frequency 73 (57%) with a mean age of 31 years 
(table 1).
The parotid gland was the commonest site of occurrence for 
these benign salivary gland tumours accounting for 101 
(97%) of cases, while the sublingual gland was the least 
affected site accounting for 7(6%) of all benign cases (table 
2).
Pleomorphic adenoma was the commonest benign salivary 
gland tumour accounting for 115 (90%) of all benign 
tumours (table 1). Only one case of basal cell adenoma was 
found (table 1).
Discussion
Of the 202 salivary gland tumours received during the 
period of study, 128 (63%) were benign while the remaining 
74 (37%) were malignant (fig 1) with a ratio of benign : 
Malignant (1.7:1). This is consistent with findings reported 
in Ibadan by Kolude B et al, in Maiduguri by Otoh EE et al, 
in Tazania by Masanga MI et al and in western literatures by 
Stell et al who all reported higher ratios of benign over 
malignant salivary gland tumours [2][4].
Of the 128 benign salivary gland tumours studied, the 
distribution showed a slight male preponderance over 
females (1.2:1) [fig 2]. This findings differ from that from 
centres in Ibadan and Lagos who reported a slight female 
preponderance over male [4][7]. The higher male 
preponderance in this study might be connected to the 
sample size and some cultural factors that do not allow 
females attend clinic alone without permission from their 
male counterparts in the Northern part of Nigeria which is 
our study area.
The age group 31-40 years accounts for the highest 
percentage (57%) of benign tumours (Table 1). This is 
similar to findings in other Nigerian, African and European 
studies [5][6][7]. Thus benign salivary gland tumours 
generally occur in relatively younger age group than the 
malignant ones.
The parotid gland was found to be the commonest site of 
occurrence for benign lesions accounting for the highest 
percentage (79%) followed by submandibular gland 
(16.0%) and sublingual gland (6%) (table 2). This is similar 
to findings in other Nigerian, African and European studies 
[5][6][7]. Thus, the largest salivary gland (parotid) remains 
the commonest site for benign salivary gland tumours.
Conclusion
This descriptive study of benign salivary gland tumours 
shows that it remains the commonest form of salivary gland 
tumour with the parotid gland as the commonest site of its 
occurrence. Pleomorphic adenoma is still the commonest 
histologic form of benign salivary gland tumour. The 
relatively higher male preponderance over females might be 
due to sample size and certain cultural factors that reduce 
female hospital attendance in our centre.
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ABSTRACT
Background
 Salivary gland tumours are common head and neck tumours which account for 2.8 to 10% of all head and neck tumours in 
most African studies and 8.0 to 10.5 % in most western literature. Benign salivary gland tumours are the commonest form of 
salivary gland neoplasm, with the ratio of benign to malignant tumours ranging from 1.2:1 to 2:1.
Objectives: This study is aimed at describing the histological pattern, age, sex and site distribution of benign salivary gland 
tumours in Jos University Teaching Hospital from January 1997 to December 2006.
Methods: This was a descriptive study of all histotogically confirmed benign salivary gland tumours over a period of ten 
years. The slides were reported independently by four pathologists. Diagnosis was made and classification done according to 
the World Health Organization (WHO) classification of salivary gland tumours. Data such as age, sex and site of distribution 
of these tumours were obtained from the patient's case files.
Results: Results show that benign salivary gland tumours had a higher distribution than malignant salivary gland tumours 
with a ratio of 1.7:1. Of these benign salivary gland tumours, male predominance over females was generally observed. 
Benign salivary gland tumours occurred more within the age range 4 to 49 years (table 1), with pleomorphic Adenoma 
accounting for the highest frequency (115) and basal cell adenoma for the lowest frequency (1) [table 2]. Parotid gland was 
also the commonest site of occurrence of most of these lesions except for basal cell adenoma which was found in the 
sublingual gland.
Introduction
Salivary gland tumours are relatively uncommon compared 
to other tumours and is said to account for less than a 2% of 
all human tumours [1]. They are however common head and 
neck tumours accounting for 2.8 to 10% of all head and neck 
tumours in African studies and 8.0 to 10.5% in western 
literatures [1][2]. Benign Salivary Gland tumours is said to 
be more common than malignant ones accounting for ratio 
between 1.2:1 to 3.5:1 in most studies [2]
Aetiology of Salivary Gland tumours is relatively unknown 
and high risk population have not been identified except for 
the rare lymphoepithelioma-like carcinoma[2]. Irradiation, 
genetic factors and   diet are possible attributable actors [2].
About 65% to 85% of Salivary Gland tumours arise within 
the parotid, 10% in the submadibular gland and the 
remainder in minor salivary glands [2]. The likelihood of a 
salivary gland tumour being benign is directly proportional 
to the size of the gland of origin [2] [3].
In Africa only few studies on Salivary Gland tumours have 
been reported mainly in Tanzania, Kenya, Nigeria  with 
prevalence of Salivary Gland Tumour ranging from 2.8% to 
10% in these countries[4][5] slightly different from that of 
the western world which is 8.0% to 10.5% [6].
In Nigeria, prevalence of salivary gland tumours is reported 
to range between 2.8 -10% [7] [8].
In all the various centers in Nigeria, Africa and western 
world benign salivary gland tumour stands out as the 
commonest Salivary gland tumour with pleomorphic 
adenoma being the  commonest histological type [8][9]. 
Parotid gland also stands out as the commonest site of 
occurrences of most of these benign lesions [8] [9] [10].
This study is the first comprehensive study of such in Jos 
University Teaching Hospital JUTH) and findings will form 
the basis for health planning and further research.
Methods
This was a descriptive study of all histological confirmed 
benign salivary gland tumours over a period of ten years. 
The study was conducted at Jos University Teaching 
Hospital (JUTH) Jos which is located in Jos city of Plateau 
State in North Central region of Nigeria. It has a 530 bed 
capacity and serves as a referral centre for most private, 
missionary and Government hospitals in this region. The 
histopathology laboratory of the hospital receives about 30-
40 salivary gland specimens annually.
Fresh sections of tissue blocks of all histologically 
confirmed benign salivary gland tumours over the period of 
study were made. The tissues were mainly excisional and 
incisional biopsies of salivary gland lesions. The sections 
were cut using the microtome (3 microne). They were made 
into slides and stained with Hematoxylin and Eosin (H and 
E) and Periodic Acid Schiff (PAS) stains. The H and E stain 
is the routine stain that help differentiate the nucleus from 
the cytoplasm of various cells. Periodic Acid Schiff is a 
special stain mainly use in this study to stain for mucin and 
glycogen to show the different type of stromal components 
in cases of pleomorphic adenoma (benign mixed tumour).
The slides were reported independently by four 
pathologists. Diagnosis was made and classification done 
according to the World Health Organization (WHO) 
classification of salivary gland tumours [16]. Informations 
such as age, sex, site were also retrieved from patient's case 
files. 
The data was analyzed using statistical mean, chi-square 
and P value. Deductions observed were then discussed.
Results
Of the 202 Salivary Gland tumours received, a total of 128 
were benign salivary gland tumours (fig. 1). Out of this 69 
(54%) were males and 59 (46%) were females (fig 2) with a 
male to female ratio of 1:2:1.
The age range for the benign tumours was between 4-
49years with the age group 31-40 years accounting for the 
highest frequency 73 (57%) with a mean age of 31 years 
(table 1).
The parotid gland was the commonest site of occurrence for 
these benign salivary gland tumours accounting for 101 
(97%) of cases, while the sublingual gland was the least 
affected site accounting for 7(6%) of all benign cases (table 
2).
Pleomorphic adenoma was the commonest benign salivary 
gland tumour accounting for 115 (90%) of all benign 
tumours (table 1). Only one case of basal cell adenoma was 
found (table 1).
Discussion
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74 (37%) were malignant (fig 1) with a ratio of benign : 
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Stell et al who all reported higher ratios of benign over 
malignant salivary gland tumours [2][4].
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distribution showed a slight male preponderance over 
females (1.2:1) [fig 2]. This findings differ from that from 
centres in Ibadan and Lagos who reported a slight female 
preponderance over male [4][7]. The higher male 
preponderance in this study might be connected to the 
sample size and some cultural factors that do not allow 
females attend clinic alone without permission from their 
male counterparts in the Northern part of Nigeria which is 
our study area.
The age group 31-40 years accounts for the highest 
percentage (57%) of benign tumours (Table 1). This is 
similar to findings in other Nigerian, African and European 
studies [5][6][7]. Thus benign salivary gland tumours 
generally occur in relatively younger age group than the 
malignant ones.
The parotid gland was found to be the commonest site of 
occurrence for benign lesions accounting for the highest 
percentage (79%) followed by submandibular gland 
(16.0%) and sublingual gland (6%) (table 2). This is similar 
to findings in other Nigerian, African and European studies 
[5][6][7]. Thus, the largest salivary gland (parotid) remains 
the commonest site for benign salivary gland tumours.
Conclusion
This descriptive study of benign salivary gland tumours 
shows that it remains the commonest form of salivary gland 
tumour with the parotid gland as the commonest site of its 
occurrence. Pleomorphic adenoma is still the commonest 
histologic form of benign salivary gland tumour. The 
relatively higher male preponderance over females might be 
due to sample size and certain cultural factors that reduce 
female hospital attendance in our centre.
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Double ELISA costed #250 naira ($2) while Immunocomb 
II and Immunoconfirm costed #500 naira ($4). A total of 280 
sera were tested with 126 reactive while 258 sera were 
tested with 95 reactive in periods A and B respectively. 
Positive and negative controls from both the manufacturers 
kits and known positive hospital laboratory samples were 
used.
We collated and compared HIV antibodies tests results at 
the teaching hospital between period A and period B. A total 
of 547 sera, aseptical collected,separated, stored were then 
processed. Results obtained were analyzed using Chi square 
statistical method (analysis) and are presented below.
Results
The results obtained in periods A and B are presented below 
in tables I, II and III. 
Table I shows results obtained using Double ELISA. A total 
of 289 sera were tested and 126 sera were reactive with a 
total prevalence rate of the 43.1%.  Of the 289 sera, 172 
were from men while 117 were from women. 75 men and 51 
women were reactive respectively.
Table II shows that out of the 258 sera examined in Period B, 
172 were from men with a total of 63 positive sera while 86 
were women with a total of 32 positive sera. A total of 95 
sera were positive giving a prevalence rate of 36.8%.
Table III shows the AKTH charges during the two periods of 
study. Before the introduction of Immunoconfirmatory kit, 
N 250 ($2) were charged. After the introduction, N500 or $4 
were charged patients. X2 at 1 df P = 0.05 is highly 
significant.
Table IV shows that a total number of patients tested within 
the two periods to be 547. The overall prevalence rate was 
40.4% from 221 positive cases. The finding was significant. 
X2 at 1 df at P = 0.05 is significant.
Discussion
Our results show that from the introduction of 
Immunconfirmatory test kits, there was a doubling of the 
cost of HIV testing at the teaching hospital from two dollars 
or N250 naira to four dollars or N500 naira. This may have 
accounted for the drop in the number of patients who came 
for HIV antibody testing from 289 in period A to 258 in 
period B. A difference of 41 patients in two comparable 
periods. The second period also witnessed a reduction in the 
number of positive samples from a prevalence of 43.6% in 
period A to 36.8% in period B. HIV antibodies testing 
generally will either be reactive or non-reactive depending 
on the presence or absence of antibodies to HIV Protein (P) 
or glyco protein (gp) which include the group specific or 
core antigens (gag) P24 and P12, the envelope proteins, gp 
120/160 and gp 41, the polymerase (pol) proteins P31 and 
P66/51. There was a reduction in the number of positive 
cases when Immunoconfirmatory test was introduced. False 
positive results may have been recorded initially when there 
was absence of confirmatory tests. The causes of false 
positive ELISA may be due to the presence of Human 
leukocyte antigen (HLA) haplotypes, DR antigen in 
multiparous women, antoimmune disorders, multiple 
transfusion recipients, multiple myeloma, alcoholic 
hepatitis and recently influenza vaccination. Others include 
haemodialysis, mislabeled specimens and positive rapid 
plasma reagin (RPR) 2. These false positive reactions occur 
as a result of cross reacting antibodies. False negative are 
rarely observed but may occur if the patient recently 
acquired the HIV antigen and seroconversion has not taken 
place. Also in advanced HIV disease in which case the 
patient may have lost the ability to make HIV antibodies 
especially P24. The introduction of Immunoconfrimatory 
technique into HIV antibodies testing in this center brought 
about reliability of laboratory test results. Although the 
patients may have paid more for the investigation, as far as 
health care providers are concerned, the period brought both 
assurance and more confidence to HIV diagnosis.
Table 1: Results obtained using ELISA in Period A 
(November 1997 – May 1998)
Table 2: Results obtained in second period B 
(November 1998 – May 1999)
Table 3:Cost Distribution according to kits in the
 two Periods A and B
Table 4: Prevalence rates among hospital patients.
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Abstract
Background: When HIV antibodies testing was introduced in Aminu Kano Teaching Hospital, Kano a couple of years ago, 
Double ELISA was used to test blood samples before a particular specimen was diagnosed as reactive or non-reactive. A time 
came when immunoconfirmatory test was introduced into HIV antibodies testing for confirmations of the presence of HIV.
Objectives: This present retospective study is to review the impact of cost and quality of HIV reagent kits in the two periods A 
and B on the patients and confidence on the health care provider.
Methods: We collated and compared laboratory records for both periods of HIV antibodies testing at Aminu Kano Teaching 
Hospital Kano consisting of period A from November 1997 to May 1998 (7 months) and period B from November 1998 to May 
1999 (7months). In period A, double ELISA was used (Genie II and Immunocomb Bispot) while in period B, Immunocomb 
Bispot and Immunoconfirm II were used
Results: The results show that the cost per test increased from two hundred and fifty Naira($2) to five hundred Naira($4). 
There was a reduction on the number of patients from 289 to 258 within the two periods. But the prevalence of reactive HIV 
antibodies decreased from 43.6% to 36.8%.
Conclusion: The period when Immunoconfirmatory technique was introduced brought assurance, reliability and confidence 
to HIV diagnosis test in the centre.
Introduction
L a b o r a t o r y  t e s t i n g  o f  p a t i e n t s  f o r  H u m a n  
Immunodeficiency Virus (HIV) infection is an important 
tool in health for both patients and healthy individuals1. As 
the knowledge of HIV infection is increasing so also the 
complexity of laboratory tests for its detection is 
increasing2. Over 22 million people were estimated by the 
WHO to be infected with HIV in developing counties and 
most of which are in Sub-Sahara Africa as at year 1999-
20003,4. The first HIV antibodies detection technique was 
licensed in 1985 by the Food and Drug Administration 
(FDA) in America2,4. Since then several test kits have been 
produced and introduced into the world markets. When HIV 
antibodies testing was introduced many years ago, the 
World Health Organization (WHO) recommended that 
Double ELISA (techniques) be adopted by developing 
countries5,6 before a patient can be said to be positive for 
HIV infection. This was to avoid false results often 
associated with these technologies (first and second 
generation ELISA kits). As time went on, the government of 
Nigeria introduced a confirmatory test technique for more 
reliability of results. This present study therefore presents 
two periods A and B when the different techniques were 
introduced in our center and the effects on the patients and 
health care providers
Methods
We collated and compared both periods of HIV antibodies 
testing at Aminu Kano Teaching Hospital Kano, Nigeria 
consisting of period A from November 1997 to May 1998 (7 
months) and period B from November 1998 to May 1999 
(7months). In period A, Double ELISA was used 
comprising Genie II and Capillus kit while in period B, 
Immunocomb Bispot and Immunoconfirm II were used. 
